AcelRx Pharmaceuticals Inc (NASDAQ:ACRX) had its Buy rating reiterated by HC Wainwright with a $9.00 price target

Analyst Ratings For

AcelRx Pharmaceuticals Inc (NASDAQ:ACRX)

Story continues below

Today, HC Wainwright reiterated its Buy rating on

AcelRx Pharmaceuticals Inc (NASDAQ:ACRX) with a price target of $9.00.

There are 5 Buy Ratings, 1 Hold Ratings, no Strong Buy Ratings, no Sell Ratings on the stock.

The current consensus rating on

AcelRx Pharmaceuticals Inc (NASDAQ:ACRX) is Buy with a consensus target price of $8.30 per share, a potential 315.00% upside.

Some recent analyst ratings include

  • 11/8/2019-
    AcelRx Pharmaceuticals Inc (NASDAQ:ACRX) had its Buy rating reiterated by HC Wainwright with a $9.00 price target
  • 8/5/2019-
    AcelRx Pharmaceuticals Inc (NASDAQ:ACRX) has coverage initiated with a Outperform ➝ Outperform rating and $7.00 price target
  • 5/9/2019-
    AcelRx Pharmaceuticals Inc (NASDAQ:ACRX) had its Buy rating reiterated by LADENBURG THALM/SH SH with a $10.00 price target
  • 4/24/2019-
    AcelRx Pharmaceuticals Inc (NASDAQ:ACRX) has coverage initiated with a Buy ➝ Buy rating and $6.50 price target
  • 12/11/2018-
    AcelRx Pharmaceuticals Inc (NASDAQ:ACRX) had its Hold rating reiterated by Oppenheimer
  • On 8/26/2019 Mark G Edwards, Director, bought 15,000 with an average share price of $2.19 per share and the total transaction amounting to $32,850.00.
  • On 8/23/2019 Mark G Edwards, Director, bought 10,000 with an average share price of $2.20 per share and the total transaction amounting to $22,000.00.
  • On 6/5/2019 Vincent J Angotti, CEO, bought 5,000 with an average share price of $2.31 per share and the total transaction amounting to $11,550.00.
  • On 3/12/2019 Mark G Edwards, Director, bought 19,000 with an average share price of $2.99 per share and the total transaction amounting to $56,810.00.
  • On 2/28/2019 Pamela P Palmer, Insider, bought 840 with an average share price of $2.81 per share and the total transaction amounting to $2,360.40.
  • On 2/28/2019 Raffi Asadorian, CFO, bought 3,647 with an average share price of $2.81 per share and the total transaction amounting to $10,248.07.
  • On 2/28/2019 Vincent J Angotti, CEO, bought 3,234 with an average share price of $2.81 per share and the total transaction amounting to $9,087.54.

Recent Trading Activity for

AcelRx Pharmaceuticals Inc (NASDAQ:ACRX)
Shares of

AcelRx Pharmaceuticals Inc closed the previous trading session at with 2.04 shares trading hands.

An ad to help with our costs